Combined analysis of the primary results of the evaluation of proleukin in a randomised international study (ESPRIT) and subcutaneous recombinant, human interleukin-2 in HIV-infected patients with low CD4+ counts under active antiretroviral therapy (SILCA by Matthew Law given during the 21st Annual Conference of the Australasian Society for HIV Medicine powered by - MULTIWEBCAST

21st Annual Conference of the Australasian Society for HIV Medicine

LIST OF PRESENTATIONS/COURSES

ABOUT THIS COURSE

OTHER WEBCASTS

Webcasted Presentation

BROWSE:

ALL PRESENTATIONS/COURSES

Combined analysis of the primary results of the evaluation of proleukin in a randomised international study (ESPRIT) and subcutaneous recombinant, human interleukin-2 in HIV-infected patients with low CD4+ counts under active antiretroviral therapy (SILCA

Matthew Law

Australia

Disclosure : Grants/Research/Conference
Abbott, BMS, GlaxoSmithKline, J&J, Gilead, Roche, Boehringer, Janssen-Cilay, CSL

[More] [Less]

PRESENTATION

22 slide(s) – 00:09:36 – English – 2009-09-09

Extra Features Available

VIDEO PODCAST

SLIDE LIBRARY

Rate & Comment

A A A


Rate:
Please let us know how useful this content was for you and feel free to write your comments below.

Disclaimer ^{AMENDED ON January 29, 2009} | Technical Support

USER ACKNOWLEDGES AND AGREES THAT ALL DECISIONS MADE WITH THE ASSISTANCE OR USE OF THE SOFTWARE AND/OR THE WEBSITE AND/OR BASED ON CONTENT FOUND HEREIN WILL BE EXCLUSIVELY THE RESPONSIBILITY OF THE USER.